Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US)-Reference-Cited by-同舟云学术

Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US)

Published:2011-02-15 Issue:4 Volume:17 Page:597-604
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:

Author:

SHARATHKUMAR A. A.,SOUCIE J. M.,TRAWINSKI B.,GREIST A.,SHAPIRO A. D.

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2010.02463.x/fullpdf

Reference42 articles.

1. Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee;Rosamond;Circulation,2007

2. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee;Rosamond;Circulation,2008

3. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV;Darby;Blood,2007

4. Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study;Plug;J Thromb Haemost,2006

5. The changing prognosis of classic hemophilia (factor VIII “deficiency”);Jones;Ann Interna Med,1991

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perioperative management of hemophilia A during coronary artery bypass grafting with patent foramen ovale repair;Journal of Surgical Case Reports;2024-09

2. Exploring the effects of Factor Xa inhibitors on thrombin generation in people with haemophilia;Thrombosis Research;2024-05

3. Reducing the risk of atherosclerotic cardiovascular disease in people with hemophilia: the importance of primary prevention;Journal of Thrombosis and Haemostasis;2024-05

4. Emicizumab is efficacious in people with hemophilia A with comorbidities aged ≥50 years: analysis of 4 phase III trials;Research and Practice in Thrombosis and Haemostasis;2024-03

5. Thrombotic Disease in Hemophilic Patients: Is This a Paradox in a State of Hypocoagulability?;Diagnostics;2024-01-29